PTPRC and primitive neuroectodermal tumor: The key markers used to differentiate neuroblastomas from other round cell tumors include cytokeratins (for thymic tumors), CD45 (for lymphoid malignancies), and CD99 (for primitive neuroectodermal tumor).18)